Get started
Author

Alina E. Ershova

Observed names: A. E. Ershova, A. Ershova, Ершова А. Е.
ORCID: 0000-0002-5791-8360
Observed ORCID: 0000-0002-5791-8360
OpenAlex ID: A5085986433
Pseudotyped Viruses: A Useful Platform for Pre-Clinical Studies Conducted in a BSL-2 Laboratory Setting
2025 · Sofiia N. Rizatdinova, Alina E. Ershova, et al. · Biomolecules · 20
PDF
SARS-CoV-2 Binding and Neutralization Properties of Peptides Derived from N-Terminus of Human ACE2
2023 · Irina V. Astrakhantseva, Alina E. Ershova, et al. · International Journal of Molecular Sciences · 5
PDF
Direct comparison of KATUSHKA far-red fluorescent protein variants with luciferase bioluminescence in xenograft mouse models of epithelial tumor studies
2023 · K. A. Levchuk, D. A. Bogdanova, et al. · Translational Medicine · 2
PDF
Development of a Multiplexed Fluorescent Pseudovirus Neutralization Test for Simultaneous Assessment of Immunity to Three SARS-CoV-2 Variants
2026 · Sofia M. Gulova, Alina E. Ershova, et al. · Immuno
PDF
Methods for Preclinical Assessment of the Efficacy of Anticancer Medicines in vivo (Review)
2025 · M. L. Vasyutina, K. V. Lepik, et al. · Ведомости Научного центра экспертизы средств медицинского применения
Triple targeted therapy is a new perspective treatment strategy for patients with FLT3-mutated acute myeloid leukemia. the literature review and single-centre experience
2022 · A. E. Prokopyev, A. A. Shatilova, et al. · Russian Journal for Personalized Medicine
PDF
Методы доклинической оценки эффективности противоопухолевых лекарственных средств in vivo (обзор)
· Васютина М. Л., Лепик К. В., et al. · CyberLeninK (CyberLeninka)
Works count: 7
Citation count: 27
H-index: 2
I10-index: 1
Year
Topic
Type